Anhui Huaheng Biotechnology Co Ltd
SSE:688639
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Anhui Huaheng Biotechnology Co Ltd
Net Income (Common)
Anhui Huaheng Biotechnology Co Ltd
Net Income (Common) Peer Comparison
600346
002648
000301
002493
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Anhui Huaheng Biotechnology Co Ltd
SSE:688639
|
Net Income (Common)
¥449.1m
|
CAGR 3-Years
55%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Z
|
Zhejiang Juhua Co Ltd
SSE:600160
|
Net Income (Common)
¥1.1B
|
CAGR 3-Years
125%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
19%
|
|
|
Hengli Petrochemical Co Ltd
SSE:600346
|
Net Income (Common)
¥8B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Satellite Chemical Co Ltd
SZSE:002648
|
Net Income (Common)
¥5.1B
|
CAGR 3-Years
29%
|
CAGR 5-Years
37%
|
CAGR 10-Years
26%
|
|
|
Jiangsu Eastern Shenghong Co Ltd
SZSE:000301
|
Net Income (Common)
¥246.7m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-3%
|
|
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
Net Income (Common)
¥3.2B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
15%
|
CAGR 10-Years
46%
|
See Also
What is Anhui Huaheng Biotechnology Co Ltd's Net Income (Common)?
Net Income (Common)
449.1m
CNY
Based on the financial report for Dec 31, 2023, Anhui Huaheng Biotechnology Co Ltd's Net Income (Common) amounts to 449.1m CNY.
What is Anhui Huaheng Biotechnology Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
43%
Over the last year, the Net Income (Common) growth was 40%. The average annual Net Income (Common) growth rates for Anhui Huaheng Biotechnology Co Ltd have been 55% over the past three years , 43% over the past five years .
You don't have any saved screeners yet
